ReviewBiological trace element research2026
A Comprehensive Review on the Hemostatic Properties of Metal-based Materials and Substances.
Review in Biological trace element research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- In Vitro Evaluation of Anti-Inflammatory and Antioxidant Properties of a Novel Calcium Alginate-Zinc Hemostatic Biomaterial.Journal of functional biomaterials · 2026Article
- Nanometric Faujasite (FAU) Zeolite Ion-Exchanged With Metal Ions for Hemostatic and Antimicrobial Applications: A Thromboelastographic and Microbiological Study.Chemistry, an Asian journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Uncontrolled hemorrhage, caused by various factors, represents a significant medical challenge with several health implications for patients and a substantial financial burden on the healthcare systems. This issue arises from unmet needs in both clinical and non-clinical sectors due to the limited efficacy of current hemostatic products and approaches in controlling excessive blood loss. Therefore, there are urgent clinical and scientific needs to design and develop new hemostatic materials with desired efficacy, safety, lower cost, and extended storage durability. To date, various synthetic and natural-based materials have been explored for the development of effective hemostatic products in diverse forms and structures. Among these, active inorganic and metal-based components have emerged as promising clinical candidates due to their superior physicochemical properties and performance in hemorrhage control and tissue repair. Regarding the intrinsic and extrinsic roles of metallic substances in hemostasis, we aimed to review and highlight the individual blood coagulation properties of these materials and elucidate their hemostatic mechanisms at the cellular and molecular levels. To this end, the effects of different metals in the course of the hemostasis process were investigated based on previous studies, and the effective factors influencing their hemostatic properties were identified. Finally, the review identifies challenges and outlines future directions for developing innovative metal-based hemostatic agents for rapid and effective hemorrhage management.
Indexed as
Identifiers
41612113What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.